Atypical comorbidities in a child considered to have type 1 diabetes led to the diagnosis of SLC29A3 spectrum disorder

Özge Besci,Kashyap Amratlal Patel,Gizem Yıldız,Özlem Tüfekçi,Kübra Yüksek Acinikli,İbrahim Mert Erbaş,Ayhan Abacı,Ece Böber,Meral Torun Bayram,Şebnem Yılmaz,Korcan Demir
DOI: https://doi.org/10.1007/s42000-022-00352-3
2022-03-14
HORMONES
Abstract:IntroductionSLC29A3 spectrum disorder is an autosomal, recessively inherited, autoinflammatory, multisystem disorder characterized by distinctive cutaneous features, including hyperpigmentation or hypertrichosis, hepatosplenomegaly, hearing loss, cardiac anomalies, hypogonadism, short stature, and insulin-dependent diabetes.Case presentationHerein, we report a 6-year-old boy who presented with features resembling type 1 diabetes mellitus, but his clinical course was complicated by IgA nephropathy, pure red cell aplasia, and recurrent febrile episodes. The patient was tested for the presence of pathogenic variants in 53 genes related to monogenic diabetes and found to be compound heterozygous for two SLC29A3 pathogenic variants (p. Arg386Gln and p. Leu298fs).ConclusionThis case demonstrated that SLC29A3 spectrum disorder should be included in the differential diagnosis of diabetes with atypical comorbidities, even when the distinctive dermatological hallmarks of SLC29A3 spectrum disorder are entirely absent.
What problem does this paper attempt to address?